Target intelligence / Profile preview

Ankyrin repeat and LEM domain-containing protein 1 (ANKLE1)

Target
ANKLE1
Molecular classification
Endonuclease, LEM-domain protein, GIY-YIG type nuclease
01

Overview

Ankyrin repeat and LEM domain-containing protein 1 (ANKLE1) is a mammalian endonuclease characterized by a C-terminal GIY-YIG motif and an internal LEM domain. It cleaves branched DNA species, such as four-way junctions and Y-structures, and shuttles between the nucleus and cytoplasm. In normal physiology, ANKLE1 is primarily expressed in erythroblast lineage cells, where it facilitates mitochondrial genome degradation during erythropoiesis. Ectopic or high expression in non-hematopoietic cells leads to mitochondrial and genome instability, triggers DNA damage responses, and is associated with increased risk for cancer (notably breast and ovarian). Mechanistically, ANKLE1’s activity can induce mitophagy, metabolic reprogramming to increased glycolysis, and may confer resistance to apoptosis. While essential for mitochondrial clearance in maturing red blood cells, its broader physiological and pathological roles outside the erythroid lineage remain incompletely defined[1][2][3][4].

Other names
ANKRD41LEM3FLJ39369LEMD6ankyrin repeat domain-containing protein 41LEM-domain containing protein 3LEM domain containing 6
02

Biological functions

DNA cleavage (preferentially at branched DNA)Chromosome segregationGenome integrity maintenanceMitochondrial DNA cleavage during erythropoiesisRegulation of mitophagyCellular metabolic regulation (shifts glycolysis vs. oxidative phosphorylation when ectopically expressed)
03

Disease associations

Cancer (especially breast and ovarian cancer risk)Genome instabilityApoptosis resistancePossibly involved in DNA repair (hypothesized from homology)
04

Safety considerations

Ectopic expression can promote genome instabilityResistance to apoptosis in non-erythroid cells, which may enable malignant transformationMetabolic reprogramming of cells (Warburg effect) when overexpressed

Beyond the preview

Go deeper on Ankyrin repeat and LEM domain-containing protein 1 (ANKLE1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat and LEM domain-containing protein 1 (ANKLE1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call